Showing 51-60 of 1100 results for "".
Rosacea Comorbidities and Skincare with Energy-Based Devices
https://practicaldermatology.com/programs/practical-dermatology/rosacea-comorbidities-and-skincare-with-energy-based-devices/35895/Ted Lain, MD, MBA, discusses the gut-skin connection as it relates to rosacea, as well as skincare with energy-based devices, at Music City SCALE 2025.Micromanagement: Microparticles Enhance Outcomes of Energy-based Acne Care
https://practicaldermatology.com/topics/general-topics/micromanagement-microparticles-enhance-outcomes-of-energy-based-acne-care/20384/With recent FDA-clearance, microparticles are available to support Nd:YAG based treatment of inflammatory acne.Kamedis Botanically-based Regimen for Dandruff
https://practicaldermatology.com/topics/general-topics/kamedis-botanically-based-regimen-for-dandruff/18579/Kamedis brings innovation to the treatment of seborrheic dermatitis (SD, also called dandruff) with a botanically-based 2-step hair care system. The two-step Kamedis system for seborrheic dermatitis consists of SEBOMedis Anti-Dandruff Shampoo and Scalp Lotion. Botanical ingredients include indigo (IDermWireTV: Pulse's CellFX, Soliton's RAP Technology, Belotero Balance (+), Restylane Defyne, Eczema Costs
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pulses-cellfx-solitons-rap-technology-belotero-balance-restylane-defyne-eczema-costs/19899/The FDA has cleared Pulse Biosciences’ CellFX system, and a commercial rollout will begin soon. There’s another new option for treatment for legs with FDA clearance of Soliton’s Rapid Acoustic Pulse technology for cellulite. For eight percent of Americans with atopic dermatitis, annual out of pocketThe Use of Lasers and Energy-Based Devices in Patients with Richly Pigmented Skin
https://practicaldermatology.com/programs/practical-dermatology/the-use-of-lasers-and-energy-based-devices-in-patients-with-richly-pigmented-skin/18199/In the last of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Andrew Alexis, MD, a dermatologist from New York City and the President of the Skin of Color Society, Corey Hartman, MD, a dermatologist in Birmingham, Alabama, and Janiene Luke, MD, a dermatoloOpportunities and Barriers in Teledermatology
https://practicaldermatology.com/conferences/aad-2021/opportunities-and-barriers-in-teledermatology/19923/Dermatologists' participation in telemedicine has increased exponentially over the past year. But what does the future hold? What opportunities exist and what challenges remain? Jules Lipoff, MD weighs in.Gratitude and Baditude Revisited: Give an Inch and the Mile Gets Shorter
https://practicaldermatology.com/columns/editors-message/gratitude-and-baditude-revisited-give-an-inch-and-the-mile-gets-shorter/23224/Backdoor Roth IRA Strategy
https://practicaldermatology.com/topics/practice-management/backdoor-roth-ira-strategy/20428/An effective step toward tax diversification.Open Access: Thoughts for the Ballot Box
https://practicaldermatology.com/topics/practice-management/open-access-thoughts-for-the-ballot-box/20908/Access to drugs, derms at stake in US presidential election.Basal Cell Carcinoma in Skin of Color: Diagnosis and Treatment Considerations
https://practicaldermatology.com/topics/general-topics/basal-cell-carcinoma-in-skin-of-color-diagnosis-and-treatment-considerations/21177/BCC may be less common in more darkly pigmented skin, but it occurs, and diagnosis may be delayed. Appropriate treatment is crucial.